David Larsen
Stock Analyst at BTIG
(1.96)
# 2,821
Out of 4,814 analysts
73
Total ratings
31.58%
Success rate
-5.47%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Upgrades: Buy | $28 | $21.44 | +30.60% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $27.22 | +28.58% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $84.52 | +53.81% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $18.77 | +65.16% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $143.91 | +80.67% | 2 | Nov 1, 2024 | |
| SLP Simulations Plus | Maintains: Buy | $60 → $50 | $32.66 | +53.12% | 2 | Oct 24, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $16.60 | +20.48% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $31.35 | +123.29% | 1 | Oct 3, 2024 | |
| DH Definitive Healthcare | Initiates: Buy | $7 | $2.53 | +177.23% | 1 | Sep 17, 2024 | |
| VEEV Veeva Systems | Initiates: Buy | $240 | $220.66 | +8.76% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $2.12 | +230.97% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $5.10 | +174.78% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.24 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $30.27 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $53.20 | - | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $8.97 | +401.67% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $3.85 | +445.45% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $4.00 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.68 | +47.80% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.83 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $5.55 | +1,611.71% | 2 | Oct 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $6.99 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $134.68 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $697.08 | -77.05% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $10.80 | +548.15% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $64.28 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $67.28 | +26.34% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $6.65 | +245.86% | 1 | Nov 2, 2017 |
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $21.44
Upside: +30.60%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $27.22
Upside: +28.58%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $84.52
Upside: +53.81%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $18.77
Upside: +65.16%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $143.91
Upside: +80.67%
Simulations Plus
Oct 24, 2024
Maintains: Buy
Price Target: $60 → $50
Current: $32.66
Upside: +53.12%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $16.60
Upside: +20.48%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $31.35
Upside: +123.29%
Definitive Healthcare
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $2.53
Upside: +177.23%
Veeva Systems
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $220.66
Upside: +8.76%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $2.12
Upside: +230.97%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $5.10
Upside: +174.78%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.24
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $30.27
Upside: -
Oct 13, 2022
Initiates: Neutral
Price Target: n/a
Current: $53.20
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $8.97
Upside: +401.67%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $3.85
Upside: +445.45%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $4.00
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $23.68
Upside: +47.80%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $6.83
Upside: -
Oct 26, 2021
Maintains: Buy
Price Target: $80 → $95
Current: $5.55
Upside: +1,611.71%
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $6.99
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $134.68
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $697.08
Upside: -77.05%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $10.80
Upside: +548.15%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $64.28
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $67.28
Upside: +26.34%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $6.65
Upside: +245.86%